isoxazoles has been researched along with Carcinoma, Pancreatic Ductal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, CA; Carbone, F; Carugo, A; Deem, AK; Draetta, GF; Feng, N; Genovese, G; Heffernan, TP; Huang, JK; Inoue, A; Lissanu Deribe, Y; Maitra, A; Msaouel, P; Perelli, L; Poggetto, ED; Robinson, FS; Rose, JL; Soeung, M; Takeda, M; Tannir, NM; Tomihara, H; Viale, A | 1 |
| Eshleman, JR; Gulla, A; Kazlauskas, E; Liang, H; Matulis, D; Petrauskas, V; Strupas, K | 1 |
| Hedley, D; Krzyzanowska, MK; Moore, MJ; Renouf, DJ; Schmuck, M; Wang, L | 1 |
1 trial(s) available for isoxazoles and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Disease-Free Survival; Female; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Male; Middle Aged; Neoplasm Metastasis; Resorcinols; Survival Rate; Treatment Outcome | 2016 |
2 other study(ies) available for isoxazoles and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Proliferation; DNA-Binding Proteins; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Mice; Mice, Nude; Pancreatic Neoplasms; Prognosis; Resorcinols; Transcription Factors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Heat Shock Protein 90 Inhibitor Effects on Pancreatic Cancer Cell Cultures.
Topics: Adenosine Triphosphatases; Antineoplastic Agents; Benzamides; Benzoquinones; Carcinoma, Pancreatic Ductal; Cell Culture Techniques, Three Dimensional; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Isoxazoles; Lactams, Macrocyclic; Molecular Structure; Pancreatic Neoplasms; Resorcinols; Rifabutin; Triazoles | 2021 |